Reach3 Insights Launches AI-Powered Pharma Research Solutions
Event summary
- Reach3 Insights introduced three new pharma-focused solutions on September 9, 2026, targeting ATU, patient journey, and communications research.
- The solutions combine mobile-first conversational research with AI-powered moderation and text message-based notifications.
- Reach3 will showcase the solutions in a webinar featuring Novartis on September 10, 2026.
- Reach3 was recognized as a Top 5 most innovative full-service agency in Greenbook's 2025 GRIT report.
The big picture
Reach3 Insights is leveraging AI to transform traditional pharma research methods, aligning with the broader industry trend of digitizing patient and HCP engagement. The launch of these solutions positions Reach3 as a key player in the AI-driven insights space, potentially reshaping how pharma companies gather and analyze data. The inclusion of Novartis in the upcoming webinar underscores the strategic importance of these new offerings.
What we're watching
- Adoption Pace
- How quickly pharma companies will integrate Reach3's AI-powered solutions into their research frameworks.
- Competitive Response
- Whether competitors will develop similar AI-accelerated research tools to challenge Reach3's offerings.
- Market Expansion
- The pace at which Reach3 can expand these solutions beyond pharma into other healthcare sectors.
Related topics